Showing results (51-60 of 119) with videos related to
Sort By:
Pageof 12
Pathology, Research and Practice|March 25, 2018
VEGFR-2 as a novel predictor of survival in gastric cancer: A systematic review and meta-analysisTeng Li, Jing Yu, Xinyu Luo, et al.Journal of Cancer|January 2, 2020
Risk of immune-related diarrhea with PD-1/PD-L1 inhibitors in different cancer types and treatment regimensLei Zhao, Jing Yu, Jing Wang, et al.Medicine|September 21, 2017
Cronkhite-Canada syndrome associated with colon cancer metastatic to liver: A case reportJing Wang, Lei Zhao, Nina Ma, et al.Frontiers in Bioscience (Landmark Edition)|October 13, 2020
Prognostic gene profiles in the tumor microenvironment of ovarian serous adenocarcinomaRuyue Tian, Guiping Zhao, Anni Zhou, et al.Anti-Cancer Drugs|July 15, 2021
Safety and efficacy of spleen aminopeptide oral lyophilized powder for improving quality of life and immune response in patients with advanced breast cancer: a multicenter, randomized, double-blind, placebo-controlled clinical trialJing Wang, Xiao Ma, Kun Shang, et al.Human Immunology|December 31, 2013
Association between LMP2/LMP7 genetic variability and the metastasis risk of ovarian cancer in Chinese women in BeijingLi Song, Nina Ma, Lei Han, et al.Molecular Medicine (Cambridge, Mass.)|January 6, 2021
Role of long non-coding RNA H19 in therapy resistance of digestive system cancersJingting Wang, Xiao Ma, Hai Si, et al.Frontiers in Oncology|June 14, 2021
Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-AnalysisJiexuan Hu, Ruyue Tian, Yingjie Ma, et al.Cancer Immunology, Immunotherapy : CII|September 3, 2010
Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancerBangwei Cao, Linzhong Zhu, Shengtao Zhu, et al.BMC Cancer|March 4, 2023
Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosisHongchao Zhen, Jizheng Tian, Guangxin Li, et al.Pageof 12